Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Ryan Hogg

Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug

(Credit: Jakub Porzycki—NurPhoto via Getty Images)

It took some time, but Novo Nordisk may be facing the first real test of its dominance in the weight loss market after pharmaceutical giant Eli Lilly won approval for its own Wegovy rival.

U.S. regulators signed off on Eli Lilly’s diabetes drug Zepbound, which can also be used to aid weight loss. The drug was found to help patients lose 18% of their body weight in control trials. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.